5.690USD-5.48%Mkt Cap: 72.71M $P/E: —1d ago
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, w…
Industry Peers
Packaged FoodsIndicators:|
Key Statistics
Company
Market Cap72.71M $
Enterprise Value93.03M $
Revenue (TTM)134.00K $
Gross Profit157.00K $
Net Income (TTM)-26.17M $
Revenue/Share0.0130 USD
Last Price5.690 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees76
CountryUS
SectorConsumer Defensive
IndustryPackaged Foods
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.18
PEG—
EV/EBITDA-4.74
EV/Revenue694.29
P/S542.60
P/B-3.56
EPS (TTM)-3.25
EPS (Forward)-1.79
52W Range
3.25024% of range13.50
52W High13.50 USD
52W Low3.250 USD
Profitability
Gross Margin78.50%
Oper. Margin-13740.00%
EBITDA Margin0.00%
Profit Margin-13086.50%
ROE148.78%
ROA-144.35%
Growth
Revenue Growth-81.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.55M $
CapEx (TTM)39.00K $
FCF Margin-8638.90%
FCF Yield-15.92%
Net Debt16.11M $
Net Debt/EBITDA-0.82
Balance Sheet
Debt/Equity-1.23
Current Ratio1.94
Quick Ratio1.40
Book Value/Sh-1.5970 USD
Cash/Share0.4650 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJul 11, 2024
Analyst Consensus
Rating—
Target (Mean)32.20 USD
Upside (mean)+465.9%
Target Range20.00 USD – 50.00 USD
$20.00+465.9% to mean$50.00
# Analysts5
Ownership
Shares Out.12.78M
Float10.50M
Insiders17.06%
Institutions20.44%
Short Interest
Short Ratio9.6d
Short % Float10.35%
Short % Out.7.74%
Shares Short988.91K
Short (prev mo.)1.13M
Technical
SMA 506.279 (-9.4%)
SMA 2006.549 (-13.1%)
Beta0.92
S&P 52W Chg20.25%
Avg Vol (30d)83.93K
Avg Vol (10d)50.48K
Technical Indicators
RSI (14)40.9
MACD-0.0026
MACD Signal0.0040
MACD Hist.-0.0067
BB Upper6.441 USD
BB Middle6.035 USD
BB Lower5.629 USD
BB Width13.44%
ATR (14)0.4004 USD
Vol Ratio (20d)1.23x